By identifying PLC-γ and the cGAS-STING pathway as key mediators of these processes, and highlighting the potential of HPX administration, this research offers promising therapeutic strategies for addressing sepsis-associated immune dysfunction. The gene discussed is STING1; the disease is Sepsis.